| Application no. and date | 20730185.4 (espacenet) (Federated) (European Patent Register), 20200408 | | Patent/reg. no. and date | DK/EP 3953393, 20221214 | | Publication date | 20220216 | | Priority no. and date | EP 19168253, 20190409 | | EP pub. no. and date |
EP 3953393 20220216 | | Effective date | | | Applicant/owner | Rottapharm Biotech S.r.l., Via Valosa di Sopra 9
20900 Monza, IT | | Applicant ref. no. | V454674DK00 | | Inventor | Caselli, Gianfranco, Via G. Sidoli, 22
20129 MILANO, IT,
ROVATI, Lucio Claudio, Via Ramazzotti, 1
20900 Monza, IT,
GIORDANI, Antonio, Via Angelini, 64D
27100 Pavia, IT,
PIEPOLI, Tiziana, Via Tertulliano, 38
20137 Milano, IT,
MAGGIONI, Daniele, Via Milano, 48
23816 Barzio, IT,
BONAZZI, Albino, Via Agordat, 4
20127 Milano, IT,
MAGARACI, Filippo, Via Monte Bianco, 25
20090 MONZA, IT | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , C07K 16/30 (2006.01) | | Title | Farmaceutisk kombination af en EP4-antagonist og immun-checkpoint-inhibitorer til behandling af tumorer | | Int. application no. | EP2020060054 | | Int. publication no. | WO2020208088 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
